Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach

References

• Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment Coronavirus (COVID-19). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 cited 2020 Mar 22. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/
   Google Scholar
• Giri R, Bhardwaj T, Shegane M, et al. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses. Cell Mol Life Sci [Internet]. 2020; Available from: https://doi.org/10.1007/s00018-020-03603–x
   Google Scholar
• Xu X-W, Wu -X-X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ [Internet]. 2020 cited 2020 Mar 22;368. Available from: https://www.bmj.com/content/368/bmj.m606
   Google Scholar
• Chakraborty C, Sharma AR, Sharma G, et al. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24:4016–4026.
   PubMed Web of Science ®Google Scholar
• Chan JFW, Li KSM, To KKW, et al. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect. 2012;65:477–489.
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan JFW, Azhar EI, et al. Coronaviruses — drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15:327–347.
   PubMed Web of Science ®Google Scholar
• Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544.
   PubMed Web of Science ®Google Scholar
• de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–534.
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier HJ, Bickerton E, Britton P, editors. Coronaviruses methods protoc [Internet]. New York, NY: Springer; 2015. p. 1–23. DOI:10.1007/978-1-4939-2438-7_1.
   Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–423.
   PubMed Web of Science ®Google Scholar
• Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237–261.
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269.
   PubMed Web of Science ®Google Scholar
• Tilocca B, Soggiu A, Sanguinetti M, et al. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Microbes Infect [Internet]. 2020 cited 2020 Jun 1;22:188–194. Available from: http://www.sciencedirect.com/science/article/pii/S1286457920300538
   Web of Science ®Google Scholar
• Tilocca B, Soggiu A, Musella V, et al. Molecular basis of COVID-19 relationships in different species: a one health perspective. Microbes Infect. 2020;22:218–220.
   Web of Science ®Google Scholar
• Bzówka M, Mitusińska K, Raczyńska A, et al. Structural and evolutionary analysis indicate that the SARS-CoV-2 Mpro is a challenging target for small-molecule inhibitor design. Int J Mol Sci. 2020;21:3099.
   PubMed Web of Science ®Google Scholar
• Saha A, Sharma AR, Bhattacharya M, et al. Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more. Arch Med Res [Internet]. 2020 cited 2020 Jun 1. Available from: http://www.sciencedirect.com/science/article/pii/S0188440920306998
   Web of Science ®Google Scholar
• Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020;12:254.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kong W, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428:561–564.
   PubMed Web of Science ®Google Scholar
• Lin Y, Shen X, Yang RF, et al. Identification of an epitope of SARS-coronavirus nucleocapsid protein. Cell Res. 2003;13:141–145.
   PubMed Web of Science ®Google Scholar
• Peng H, Yang L, Wang L, et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology. 2006;351:466–475.
   PubMed Web of Science ®Google Scholar
• Tang F, Quan Y, Xin Z-T, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186:7264–7268.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fett C, Zhao J, et al. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014;88:11034–11044.
   PubMed Web of Science ®Google Scholar
• Kumar Pandey R, Ojha R, Mishra A, et al. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection. J Cell Biochem. 2018;119:7631–7642.
   PubMed Web of Science ®Google Scholar
• Ojha R, Pareek A, Pandey RK, et al. Strategic development of a next-generation multi-epitope vaccine to prevent nipah virus zoonotic infection. ACS Omega. 2019;4:13069–13079.
   PubMed Web of Science ®Google Scholar
• Namvar A, Bolhassani A, Javadi G, et al. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine. Sci Rep. 2019;9:15225.
   PubMed Web of Science ®Google Scholar
• Larsen JEP, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006;2:2.
   PubMedGoogle Scholar
• Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics. 2009;10:296.
   PubMed Web of Science ®Google Scholar
• Larsen MV, Lundegaard C, Lamberth K, et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424.
   PubMed Web of Science ®Google Scholar
• Dhanda SK, Vir P, Raghava GP. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8:30.
   PubMed Web of Science ®Google Scholar
• Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4.
   PubMed Web of Science ®Google Scholar
• Magnan CN, Zeller M, Kayala MA, et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinforma Oxf Engl. 2010;26:2936–2943.
   PubMed Web of Science ®Google Scholar
• Dimitrov I, Flower DR, Doytchinova I. AllerTOP - a server for in silico prediction of allergens. BMC Bioinformatics. 2013;14:S4.
   PubMed Web of Science ®Google Scholar
• Dimitrov I, Naneva L, Doytchinova I, et al. AllergenFP: allergenicity prediction by descriptor fingerprints. Bioinforma Oxf Engl. 2013;30:846–851.
   PubMed Web of Science ®Google Scholar
• Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis tools on the ExPASy server. In: Proteomics Protoc. Handb: Humana Press; 2005. pp. 571–607. DOI:10.1385/1-59259-890-0:571.
   Google Scholar
• Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999;292:195–202.
   PubMed Web of Science ®Google Scholar
• Buchan DWA, Jones DT. The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Res. 2019;47:W402–W407.
   PubMed Web of Science ®Google Scholar
• Obradovic Z, Peng K, Vucetic S, et al. Exploiting heterogeneous sequence properties improves prediction of protein disorder. Proteins. 2005;61(Suppl 7):176–182. .
   PubMed Web of Science ®Google Scholar
• Obradovic Z, Peng K, Vucetic S, et al. Predicting intrinsic disorder from amino acid sequence. Proteins. 2003;53(Suppl 6):566–572. .
   PubMed Web of Science ®Google Scholar
• Xue B, Dunbrack RL, Williams RW, et al. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta. 2010;1804:996–1010.
   PubMed Web of Science ®Google Scholar
• Mészáros B, Erdos G, Dosztányi Z. IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic Acids Res. 2018;46:W329–W337.
   PubMed Web of Science ®Google Scholar
• Gadhave K, Gehi BR, Kumar P, et al. The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway. Cell Mol Life Sci CMLS. 2020. DOI:10.1007/s00018-019-03414-9.
   Web of Science ®Google Scholar
• Kumar A, Kumar P, Kumari S, et al. Folding and structural polymorphism of p53 C-terminal domain: one peptide with many conformations. Arch Biochem Biophys. 2020;684:108342.
   PubMed Web of Science ®Google Scholar
• Kumar D, Singh A, Kumar P, et al. Understanding the penetrance of intrinsic protein disorder in rotavirus proteome. Int J Biol Macromol. 2020;144:892–908.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan R, Roy A, et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12:7–8.
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry G, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27:221–234.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, MacArthur MW, Moss DS, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291.
   Web of Science ®Google Scholar
• Chuang G-Y, Kozakov D, Brenke R, et al. DARS (Decoys As the Reference State) potentials for protein-protein docking. Biophys J. 2008;95:4217–4227.
   PubMed Web of Science ®Google Scholar
• Kozakov D, Brenke R, Comeau SR, et al. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins. 2006;65:392–406.
   PubMed Web of Science ®Google Scholar
• Hulswit RJG, Lang Y, Bakkers MJG, et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc Natl Acad Sci USA. 2019;116:2681–2690.
   PubMed Web of Science ®Google Scholar
• Li W, Hulswit RJG, Widjaja I, et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci USA. 2017;114:E8508–E8517.
   PubMed Web of Science ®Google Scholar
• Belouzard S, Millet JK, Licitra BN, et al. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011–1033.
   PubMed Web of Science ®Google Scholar
• de Haan CAM, Te Lintelo E, Li Z, et al. Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol. 2006;80:10909–10918.
   PubMed Web of Science ®Google Scholar
• Liao Y, Yuan Q, Torres J, et al. Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein. Virology. 2006;349:264–275.
   PubMed Web of Science ®Google Scholar
• Teoh K-T, Siu Y-L, Chan W-L, et al. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Mol Biol Cell. 2010;21:3838–3852.
   PubMed Web of Science ®Google Scholar
• Wilson L, McKinlay C, Gage P, et al. SARS coronavirus E protein forms cation-selective ion channels. Virology. 2004;330:322–331.
   PubMed Web of Science ®Google Scholar
• Vennema H, Godeke GJ, Rossen JW, et al. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. Embo J. 1996;15:2020–2028.
   PubMed Web of Science ®Google Scholar
• He R, Dobie F, Ballantine M, et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem Biophys Res Commun. 2004;316:476–483.
   PubMed Web of Science ®Google Scholar
• Kuo L, Hurst-Hess KR, Koetzner CA, et al. Analyses of coronavirus assembly interactions with interspecies membrane and nucleocapsid protein chimeras. J Virol. 2016;90:4357–4368.
   PubMed Web of Science ®Google Scholar
• Bhattacharya M, Sharma AR, Patra P, et al. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J Med Virol. 2020;92:618–631.
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Sharma AR, Bhattacharya M, et al. Consider TLR5 for new therapeutic development against COVID-19. J Med Virol [Internet]. cited 2020 Jun 1. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25997
   Web of Science ®Google Scholar
• Collins AR. Human coronavirus OC43 interacts with major histocompatibility complex class I molecules at the cell surface to establish infection. Immunol Invest. 1994;23:313–321.
   PubMed Web of Science ®Google Scholar
• WHO. WHO | Coronavirus disease (COVID-2019) R&D [Internet]. World Health Organization; [ cited 2020 Apr 22]. Available from: http://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/
   Google Scholar
• Tseng C-T, Sbrana E, Iwata-Yoshikawa N, et al. Immunization with SARS Coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS ONE [Internet]. 2012 cited 2020 Apr 22;7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335060/
   Web of Science ®Google Scholar
• Guy AJ, Irani V, MacRaild CA, et al. Insights into the immunological properties of intrinsically disordered malaria proteins using proteome scale predictions. PloS One. 2015;10:e0141729.
   PubMed Web of Science ®Google Scholar